跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-LAMOTRIGINE 25MG TABLET - HSA Drug Approval Details
Approvals
/
HSA
/
APO-LAMOTRIGINE 25MG TABLET
Approved
THERAPEUTIC
APO-LAMOTRIGINE 25MG TABLET
APOTEX INC (CANADA)
🇸🇬 Health Sciences Authority
Approval Date
Sep 15, 2008
Approval ID
a2132a025e9b147d
Company
APOTEX INC (CANADA)
Type
Therapeutic
Approval Details
Approval Id
a2132a025e9b147d
Drug Name
APO-LAMOTRIGINE 25MG TABLET
Product Name
APO-LAMOTRIGINE 25MG TABLET
Approval Number
SIN13554P
Approval Date
2008-09-15
Registrant
PHARMAFORTE SINGAPORE PTE LTD
Licence Holder
PHARMAFORTE SINGAPORE PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
N03AX09
Atc Item Name
lamotrigine
Pharma Manufacturer Name
PHARMAFORTE SINGAPORE PTE LTD
Active Ingredients
Lamotrigine
25.0 mg
LAMOTRIGINE
25 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Sep 15, 2008
Approval ID
a2132a025e9b147d
Type
Therapeutic
Back to HSA Approvals